3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
cyclopia sequence
14
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Multiple Myeloma
3
Breast Neoplasms
3
Pain
2
Neoplasms, Plasma Cell
2
Head and Neck Neoplasms
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Thromboembolism
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Sleepiness
1
Sezary Syndrome
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Cognitive Complications
1
Peripheral Nervous System Diseases
1
Peptic Ulcer
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Parasomnias
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Interventions
Fluorouracil
218
Leucovorin
201
Oxaliplatin
191
Irinotecan
148
Bevacizumab
107
Capecitabine
93
Cetuximab
89
Folfox protocol
54
Chemotherapy, Adjuvant
34
Panitumumab
30
pembrolizumab
23
Nivolumab
22
Colonoscopy
22
Gemcitabine
20
Magnetic Resonance Spectroscopy
19
Floxuridine
19
IFL protocol
18
Celecoxib
18
Radiotherapy
17
Neoadjuvant Therapy
17
Early Intervention, Educational
17
Drug Therapy
17
Laparoscopy
14
Cyclophosphamide
14
Counseling
14
trifluridine tipiracil drug combination
13
regorafenib
13
XELOX
13
Exercise
13
Erlotinib Hydrochloride
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Colonic Neoplasms
×
Minocycline
×
Clear all
NCT02928692
2020-01-28
MAPOCD
RenJi Hospital
Phase 3
Unknown
750 enrolled